BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 23073339)

  • 21. Boston keratoprosthesis type I in the elderly.
    Homayounfar G; Grassi CM; Al-Moujahed A; Colby KA; Dohlman CH; Chodosh J
    Br J Ophthalmol; 2017 Apr; 101(4):514-518. PubMed ID: 27381593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of pars plana glaucoma drainage implant in Boston type 1 keratoprosthesis surgery.
    Huh ES; Aref AA; Vajaranant TS; de la Cruz J; Chau FY; Cortina MS
    J Glaucoma; 2014 Jan; 23(1):e39-44. PubMed ID: 24370810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Refractive and corneal aberrometric changes after intracorneal ring implantation in corneas with pellucid marginal degeneration.
    Piñero DP; Alio JL; Morbelli H; Uceda-Montanes A; El Kady B; Coskunseven E; Pascual I
    Ophthalmology; 2009 Sep; 116(9):1656-64. PubMed ID: 19643482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases.
    Chang HY; Luo ZK; Chodosh J; Dohlman CH; Colby KA
    Cornea; 2015 Mar; 34(3):264-70. PubMed ID: 25611395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of Intacs for post-LASIK corneal ectasia.
    Kymionis GD; Tsiklis NS; Pallikaris AI; Kounis G; Diakonis VF; Astyrakakis N; Siganos CS
    Ophthalmology; 2006 Nov; 113(11):1909-17. PubMed ID: 17074560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency.
    Aravena C; Bozkurt TK; Yu F; Aldave AJ
    Cornea; 2016 Sep; 35(9):1156-64. PubMed ID: 27387566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International Outcomes of the Boston Type I Keratoprosthesis in Stevens-Johnson Syndrome.
    Alexander JK; Basak SK; Padilla MD; Yu F; Aldave AJ
    Cornea; 2015 Nov; 34(11):1387-94. PubMed ID: 26382898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Boston Type I keratoprosthesis: an assessment of its efficacy and safety.
    Verdejo-Gómez L; Peláez N; Gris O; Güell JL
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):446-52. PubMed ID: 21919432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of visual outcomes following Boston type 1 keratoprosthesis implantation.
    Ahmad S; Akpek EK; Gehlbach PL; Dunlap K; Ramulu PY
    Am J Ophthalmol; 2015 Apr; 159(4):739-47. PubMed ID: 25555801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Visual Outcomes, Complications, and Retention of the Boston Type I Keratoprosthesis.
    Aravena C; Yu F; Aldave AJ
    Cornea; 2018 Jan; 37(1):3-10. PubMed ID: 28990994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with Boston keratoprosthesis type 1 in the developing world.
    de Oliveira LA; Pedreira Magalhães F; Hirai FE; de Sousa LB
    Can J Ophthalmol; 2014 Aug; 49(4):351-7. PubMed ID: 25103652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term visual acuity, retention and complications observed with the type-I and type-II Boston keratoprostheses in an Irish population.
    Duignan ES; Ní Dhubhghaill S; Malone C; Power W
    Br J Ophthalmol; 2016 Aug; 100(8):1093-7. PubMed ID: 26628625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Boston keratoprosthesis in Stevens-Johnson syndrome.
    Sayegh RR; Ang LP; Foster CS; Dohlman CH
    Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glaucoma associated with keratoprosthesis.
    Netland PA; Terada H; Dohlman CH
    Ophthalmology; 1998 Apr; 105(4):751-7. PubMed ID: 9544652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
    Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
    Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes following Boston type 1 keratoprosthesis implantation in aniridia patients at the University of Montreal.
    Hassanaly SI; Talajic JC; Harissi-Dagher M
    Am J Ophthalmol; 2014 Aug; 158(2):270-276.e1. PubMed ID: 24844976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
    Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
    Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complications associated with clear corneal cataract wounds during vitrectomy.
    Wong RW; Kokame GT; Mahmoud TH; Mieler WF; Tornambe PE; McDonald HR
    Retina; 2010 Jun; 30(6):850-5. PubMed ID: 20090563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis.
    Cade F; Grosskreutz CL; Tauber A; Dohlman CH
    Cornea; 2011 Dec; 30(12):1322-7. PubMed ID: 22001817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medium-term outcomes of boston type 1 keratoprosthesis implantation in Bangkok, Thailand.
    Lekhanont K; Thaweesit P; Muntham D; Chuckpaiwong V; Vongthongsri A
    Cornea; 2014 Dec; 33(12):1312-9. PubMed ID: 25285588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.